BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 17537410)

  • 21. Pigment epithelium-derived factor inhibits glioma cell growth in vitro and in vivo.
    Zhang T; Guan M; Xu C; Chen Y; Lu Y
    Life Sci; 2007 Sep; 81(16):1256-63. PubMed ID: 17919663
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Survival and stimulation of neurite outgrowth in a serum-free culture of spiral ganglion neurons from adult mice.
    Vieira M; Christensen BL; Wheeler BC; Feng AS; Kollmar R
    Hear Res; 2007 Aug; 230(1-2):17-23. PubMed ID: 17521837
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effect of MX-2, a morpholino anthracycline derivative, against human and rat glioma cells and experimental leptomeningeal tumors in rats].
    Izumoto S; Arita N; Ushio Y; Hayakawa T; Ohnishi T; Taki T; Yamamoto H; Oku Y; Mogami H; Komeshima N
    Gan To Kagaku Ryoho; 1988 May; 15(5):1765-9. PubMed ID: 3369870
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phospholipids and fatty acids in human brain tumors.
    Ledwozyw A; Lutnicki K
    Acta Physiol Hung; 1992; 79(4):381-7. PubMed ID: 1343190
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dual-targeting topotecan liposomes modified with tamoxifen and wheat germ agglutinin significantly improve drug transport across the blood-brain barrier and survival of brain tumor-bearing animals.
    Du J; Lu WL; Ying X; Liu Y; Du P; Tian W; Men Y; Guo J; Zhang Y; Li RJ; Zhou J; Lou JN; Wang JC; Zhang X; Zhang Q
    Mol Pharm; 2009; 6(3):905-17. PubMed ID: 19344115
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phase II study of neoadjuvant imatinib in glioblastoma: evaluation of clinical and molecular effects of the treatment.
    Razis E; Selviaridis P; Labropoulos S; Norris JL; Zhu MJ; Song DD; Kalebic T; Torrens M; Kalogera-Fountzila A; Karkavelas G; Karanastasi S; Fletcher JA; Fountzilas G
    Clin Cancer Res; 2009 Oct; 15(19):6258-66. PubMed ID: 19789313
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antiproliferative effect of quercetin in the human U138MG glioma cell line.
    Braganhol E; Zamin LL; Canedo AD; Horn F; Tamajusuku AS; Wink MR; Salbego C; Battastini AM
    Anticancer Drugs; 2006 Jul; 17(6):663-71. PubMed ID: 16917212
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antitumor compound testing in glioblastoma organotypic brain cultures.
    Biggs T; Foreman J; Sundstrom L; Regenass U; Lehembre F
    J Biomol Screen; 2011 Sep; 16(8):805-17. PubMed ID: 21807962
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cocaine cytotoxicity in serum-free environment: C6 glioma cell culture.
    Gu J; Yassini P; Goldberg G; Zhu W; Konat GW; Wiggins RC
    Neurotoxicology; 1993; 14(1):19-22. PubMed ID: 8361674
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Autocrine factors that sustain glioma invasion and paracrine biology in the brain microenvironment.
    Hoelzinger DB; Demuth T; Berens ME
    J Natl Cancer Inst; 2007 Nov; 99(21):1583-93. PubMed ID: 17971532
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Survival of patients with glioblastoma multiforme has not improved between 1993 and 2004: analysis of 625 cases.
    Tait MJ; Petrik V; Loosemore A; Bell BA; Papadopoulos MC
    Br J Neurosurg; 2007 Oct; 21(5):496-500. PubMed ID: 17852105
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Brain tumor stem cells as research and treatment targets.
    Hide T; Takezaki T; Nakamura H; Kuratsu J; Kondo T
    Brain Tumor Pathol; 2008; 25(2):67-72. PubMed ID: 18987831
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of standardized cell culture conditions for tumor cells with potential clinical application.
    Stadler G; Wieser M; Steindl F; Grillari J; Katinger H; Pfragner R; Voglauer R
    Cytotherapy; 2007; 9(5):488-98. PubMed ID: 17786610
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anticancer activity of extracts derived from the mature roots of Scutellaria baicalensis on human malignant brain tumor cells.
    Scheck AC; Perry K; Hank NC; Clark WD
    BMC Complement Altern Med; 2006 Aug; 6():27. PubMed ID: 16914050
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cellular and in vivo activity of JNJ-28871063, a nonquinazoline pan-ErbB kinase inhibitor that crosses the blood-brain barrier and displays efficacy against intracranial tumors.
    Emanuel SL; Hughes TV; Adams M; Rugg CA; Fuentes-Pesquera A; Connolly PJ; Pandey N; Moreno-Mazza S; Butler J; Borowski V; Middleton SA; Gruninger RH; Story JR; Napier C; Hollister B; Greenberger LM
    Mol Pharmacol; 2008 Feb; 73(2):338-48. PubMed ID: 17975007
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anti-tumor activities of four chelating agents against human neuroblastoma cells.
    Shen L; Zhao HY; Du J; Wang F
    In Vivo; 2005; 19(1):233-6. PubMed ID: 15796180
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effects of tibolone on the human primary glioblastoma multiforme cell culture and the rat C6 glioma model.
    Altinoz MA; Albayrak SB; Karasu A; Sabanci PA; Imer M; Bilir A
    Neurol Res; 2009 Nov; 31(9):923-7. PubMed ID: 19531283
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genomic and expression profiling of glioblastoma stem cell-like spheroid cultures identifies novel tumor-relevant genes associated with survival.
    Ernst A; Hofmann S; Ahmadi R; Becker N; Korshunov A; Engel F; Hartmann C; Felsberg J; Sabel M; Peterziel H; Durchdewald M; Hess J; Barbus S; Campos B; Starzinski-Powitz A; Unterberg A; Reifenberger G; Lichter P; Herold-Mende C; Radlwimmer B
    Clin Cancer Res; 2009 Nov; 15(21):6541-50. PubMed ID: 19861460
    [TBL] [Abstract][Full Text] [Related]  

  • 39. SU11657 enhances radiosensitivity of human meningioma cells.
    Milker-Zabel S; Zabel-du Bois A; Ranai G; Trinh T; Unterberg A; Debus J; Lipson KE; Abdollahi A; Huber PE
    Int J Radiat Oncol Biol Phys; 2008 Mar; 70(4):1213-8. PubMed ID: 18234428
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term culture of primary human lymphoblastic leukemia cells in the absence of serum or hematopoietic growth factors.
    Nijmeijer BA; Szuhai K; Goselink HM; van Schie ML; van der Burg M; de Jong D; Marijt EW; Ottmann OG; Willemze R; Falkenburg JH
    Exp Hematol; 2009 Mar; 37(3):376-85. PubMed ID: 19135770
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.